<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">epidemiology</journal-id><journal-title-group><journal-title xml:lang="ru">Эпидемиология и Вакцинопрофилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Epidemiology and Vaccinal Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-3046</issn><issn pub-type="epub">2619-0494</issn><publisher><publisher-name>«Numicom» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31631/2073-3046-2016-15-1-77-85</article-id><article-id custom-type="elpub" pub-id-type="custom">epidemiology-131</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВАКЦИНОПРОФИЛАКТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>VACCINAL PREVENTION</subject></subj-group></article-categories><title-group><article-title>Получение рекомбинантного аналога гликопротеина Е вируса Varicella zoster: клонирование, экспрессия и исследование антигенных свойств</article-title><trans-title-group xml:lang="en"><trans-title>Recombinant Analogue of Varicella Zoster Virus Glycoprotein E: Cloning, Expression and Studying of AntigEn Properties</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алаторцева</surname><given-names>Г. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Alatortseva</surname><given-names>G. I.</given-names></name></name-alternatives><email xlink:type="simple">alatortseva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сидоров</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sidorov</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">sashasidorov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нестеренко</surname><given-names>Л. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nesterenko</surname><given-names>L. N.</given-names></name></name-alternatives><email xlink:type="simple">lnnesterenko@pochta.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лухверчик</surname><given-names>Л. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Luhverchik</surname><given-names>L. N.</given-names></name></name-alternatives><email xlink:type="simple">lexx294@yandex.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Амиантова</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Amiantova</surname><given-names>I. I.</given-names></name></name-alternatives><email xlink:type="simple">amianti@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Доценко</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Docenko</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">VerraMal@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хыу</surname><given-names>Фонг Фам</given-names></name><name name-style="western" xml:lang="en"><surname>Huy</surname><given-names>Phong Pham</given-names></name></name-alternatives><email xlink:type="simple">graecumestnonlegiturhp2004@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Милованова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Milovanova</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">rose_48@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Выливанная</surname><given-names>О. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Vylivannaya</surname><given-names>O. B.</given-names></name></name-alternatives><email xlink:type="simple">Vylivannaya@dcli.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Казанова</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kazanova</surname><given-names>A. C.</given-names></name></name-alternatives><email xlink:type="simple">pendelbus@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лавров</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lavrov</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">v.f.lavrov@inbox.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зверев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zverev</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">vitalyzverev@outlook.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «НИИ вакцин и сывороток им. И.И. Мечникова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mechnikov Research Institute for Vaccines and Sera</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Диагностический центр лабораторных исследований» Департамента здравоохранения города Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State BudgEtary Institution of Public Health«Diagnostic center of laboratory researches»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «НИИ вакцин и сывороток им. И.И. Мечникова»; ГБОУ ДПО «Российская медицинская академия последипломного образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mechnikov Research Institute for Vaccines and Sera; State Educational Institution of Additional Professional Education «Medical Academy of Postgraduate Studies», Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>20</day><month>02</month><year>2016</year></pub-date><volume>15</volume><issue>1</issue><fpage>77</fpage><lpage>85</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Алаторцева Г.И., Сидоров А.В., Нестеренко Л.Н., Лухверчик Л.Н., Амиантова И.И., Доценко В.В., Хыу Ф.Ф., Милованова А.В., Выливанная О.Б., Казанова А.С., Лавров В.В., Зверев В.В., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Алаторцева Г.И., Сидоров А.В., Нестеренко Л.Н., Лухверчик Л.Н., Амиантова И.И., Доценко В.В., Хыу Ф.Ф., Милованова А.В., Выливанная О.Б., Казанова А.С., Лавров В.В., Зверев В.В.</copyright-holder><copyright-holder xml:lang="en">Alatortseva G.I., Sidorov A.V., Nesterenko L.N., Luhverchik L.N., Amiantova I.I., Docenko V.V., Huy P.P., Milovanova A.V., Vylivannaya O.B., Kazanova A.C., Lavrov V.V., Zverev V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epidemvac.ru/jour/article/view/131">https://www.epidemvac.ru/jour/article/view/131</self-uri><abstract><p>Получен рекомбинантный антиген GE, содержащий слитый с в-галактозидазой E. coli фрагмент (Gly48 - Glu135) гликопротеина E (gE) вируса Varicella zoster (VZV). Антигенная специфичность рекомбинантного антигена подтверждена с помощью вестерн-блоттинга и конкурентного иммуноферментного анализа (ИФА) в сравнении с его коммерческими аналогами и натуральными вирусными антигенами. Выявлено взаимодействие рекомбинантного белка GE с IgG кроликов, иммунизированных вакцинным штаммом вируса. Методом ИФА показано взаимодействие белка GE с 66% сывороток крови больных опоясывающим лишаем и 35% сывороток лиц из групп сравнения, в том числе, сывороток, содержащих антитела к другим вирусам герпеса, сывороток здоровых доноров, а также пациентов с различными формами кишечной патологии. Таким образом, экспериментально обоснована возможность применения полученного нами рекомбинантного GE VZV, в качестве антигена в диагностических и исследовательских целях.</p></abstract><trans-abstract xml:lang="en"><p>We made recombinant antigen GE containing fragment of VZV glycoprotein E (Gly48 - Glu135) fused to E. coli beta-galactosidase and confirmed its antigen specificity by Western blotting and competitive-inhibition enzyme immunoassay (EIA) in comparison with commercial analogues and natural viral antigens. We showed interaction of recombinant GE protein with IgG antibodies from rabbits immunized by vaccine viral strain. GE protein also specifically reacted in ELISA with 66% of sera from zoster patients and 35% of sera from control groups including sera containing antibodies to other herpes viruses, sera from healthy donors, and sera from patients with different forms of intestinal disorders. Consequently, we demonstrated possibility of application of our recombinant GE VZV as antigen for diagnostics and research use.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>вирус Varicella zoster</kwd><kwd>ORF68</kwd><kwd>гликопротеин Е</kwd><kwd>рекомбинантный антиген</kwd><kwd>иммуноферментный анализ</kwd><kwd>Varicella Zoster Virus</kwd><kwd>VZV</kwd><kwd>open reading frame 68</kwd><kwd>ORF 68</kwd><kwd>glycoprotein G</kwd><kwd>recombinant antigEn</kwd><kwd>enzyme immunoassay</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kuhn J. E., Klaffke K., Munk K., Braun R.W. HSV-1 gB and VZV gp-II crossreactive antibodies in human sera. Arch. Virol. 1990; 112: 203 - 213.</mixed-citation><mixed-citation xml:lang="en">Kuhn J. E., Klaffke K., Munk K., Braun R.W. 1990. HSV-1 gB and VZV gp-II crossreactive antibodies in human sera. Arch. Virol. 112: 203 – 213.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kutinova L., Hainz P, Ludvikova V., Maresova L., Nemeckova S. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of varicella-zoster virus. Virology. 2001; 280: 211 - 220.</mixed-citation><mixed-citation xml:lang="en">Kutinova L., Hainz P., Ludvikova V., Maresova L., Nemeckova S. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of varicella-zoster virus. Virology. 2001; 280: 211 – 220.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Montalvo E.A., Parmley R.T., Grose C. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of Nlinked and O-linked oligosaccharide moieties. J. Virol. 1985; 53: 761 - 770.</mixed-citation><mixed-citation xml:lang="en">Montalvo E.A., Parmley R.T., Grose C. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of Nlinked and O-linked oligosaccharide moieties. J. Virol. 1985; 53: 761 – 770.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Haumont M., Jacquet A., Massaer M., Deleersnyder V., Mazzu P, Bollen A. et al. Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells. Virus Res. 1996; 40: 199 - 204.</mixed-citation><mixed-citation xml:lang="en">Haumont M., Jacquet A., Massaer M., Deleersnyder V., Mazzu P., Bollen A. et al. Purification, characterization and immunogenicity of recombinant varicellazoster virus glycoprotein gE secreted by Chinese hamster ovary cells. Virus Res. 1996; 40: 199 – 204.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Grahn A., Studahl M., Nilsson S., Thomsson E., B ckstr m M., Bergstr m T. Varicella-Zoster Virus (VZV) Glycoprotein E Is a Serological AntigEn for Detection of Intrathecal Antibodies to VZV in Central Nervous System Infections, without Cross-Reaction to Herpes Simplex Virus 1. dinical and vaccine immunology. 2011; 18 (8): 1336 - 1342.</mixed-citation><mixed-citation xml:lang="en">Grahn A., Studahl M., Nilsson S., Thomsson E., Bäckström M., Bergström T. Varicella-Zoster Virus (VZV) Glycoprotein E Is a Serological AntigEn for Detection of Intrathecal Antibodies to VZV in Central Nervous System Infections, without  Cross-Reaction to Herpes Simplex Virus 1. Сlinical and vaccine immunology. 2011; 18 (8): 1336 – 1342.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Алаторцев В.Е., Алаторцева Г.И. Штамм бактерий Escherichia coli, используемый для получения рекомбинантных белков. Патент РФ, № 2043409, 1995.</mixed-citation><mixed-citation xml:lang="en">Alatortsev V.E., Alatortseva G.I. Strain of bacterium Escherichia coli used for ecombinant proteins preparing. Patent RF, № 2043409; 1995 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Алаторцев В.Е., Алаторцева Г.И. Вектор pEL5c предназначенный для экспрессии чужеродной ДНК. Патент РФ, 2071503, 1997.</mixed-citation><mixed-citation xml:lang="en">Alatortsev V.E., Alatortseva G.I. Vector pel5с designated for foreign DNA expression. Patent RF, № 20715031; 1997 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Новое в клонировании ДНК. Методы. Пер. с англ. Гловер Д., ред. Москва; 1989: 122 - 128.</mixed-citation><mixed-citation xml:lang="en">News in DNA cloning. A practical approach. Ed.: Glover D.M. Moscow; 1989: 122 – 128 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sameh Magdeldin and Annette Moser. Affinity Cromatography: Principles and applications, affinity chromatography Ed.: dr. S. Magdeldin. In Tech. 2012: 70 - 75.</mixed-citation><mixed-citation xml:lang="en">Sameh Magdeldin and Annette Moser. Affinity Cromatography: Principles and applications, affinity chromatography Ed.: dr. S. Magdeldin. In Tech. 2012: 70 – 75.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Virca G.D., Travis J., Hall PK., Roberts R.C. Purification of -2-Macroglobulin by chromatography on Cibacron Blue sepharose. Analytical Biochemistry. 1978; 8: 274 - 276.</mixed-citation><mixed-citation xml:lang="en">Virca G.D., Travis J., Hall P.K., Roberts R.C. Purification of α-2-Macroglobulin by chromatography on Cibacron Blue sepharose. Analytical Biochemistry. 1978; 8: 274 – 276.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rattana Wongchuphan, Beng Ti Tey, Wen Siang Tan, Senthil Kumar Subramanian, Farah Saleena Taip, Tau Chuan Ling. Purification of rabbit polyclonal immunoglobulin G using anion exchangers. Process Biochemistry 2011; 46: 101 - 107.</mixed-citation><mixed-citation xml:lang="en">Rattana Wongchuphan, Beng Ti Tey, Wen Siang Tan, Senthil Kumar Subramanian, Farah Saleena Taip, Tau Chuan Ling. Purification of rabbit polyclonal immunoglobulin G using anion exchangers. Process Biochemistry. 2011; 46: 101 – 107.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Практическая химия белка. Пер. с англ. Дарбре А., ред. Москва; 1989: 1 - 621.</mixed-citation><mixed-citation xml:lang="en">Practical Protein Chemistry. Ed. Darbre. A. 1989: 1 – 621 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Towbin H., Staehlin T., Gordon Y. Proc. nat. Acad. Sci. USA. 1979; 76: 4350 - 4359.</mixed-citation><mixed-citation xml:lang="en">Towbin H., Staehlin T., Gordon Y. Proc. nat. Acad. Sci. USA. 1979; 76: 4350 – 4359.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ceroni A., Sibani S., Baiker A., Pothineni V.R., Bailer S.M., LaBaer J. et al. Systematic analysis of the IgG antibody immune response against Varicella zoster virus (VZV) using a self-assembled protein microarray. Mol Biosyst. 2010; 6 (9): 1604 - 1610. Doi: 10.1039/c003798b. Epub 2010 Jun 1.</mixed-citation><mixed-citation xml:lang="en">Ceroni A., Sibani S., Baiker A., Pothineni V.R., Bailer S.M., LaBaer J. et al. Systematic analysis of the IgG antibody immune response against Varicella zoster virus (VZV) using a self-assembled protein microarray. Mol Biosyst. 2010; 6 (9): 1604 – 1610. Doi: 10.1039/c003798b. Epub 2010 Jun 1.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Vizoso Pinto M. G., Pfrepper K.-I., Janke T., Noelting C., Sander M., Lueking A. et al. A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens Virology Journal 2010, 7:165</mixed-citation><mixed-citation xml:lang="en">Vizoso Pinto M. G., Pfrepper K.-I., Janke T., Noelting C., Sander M., Lueking A. et al. A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens Virology Journal. 2010; 7: 165.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Park R., Hwang J.Y., Lee K.I., Namkoong S., Choi.SK., Park S. et al. Measurement of antibodies to varicella-zoster virus using a virus-free fluorescent-antibody-to-membrane-antigen (FAMA) test Microbiol Biotechnol. 2015; 25 (2): 268 - 273</mixed-citation><mixed-citation xml:lang="en">Park R., Hwang J.Y., Lee K.I., Namkoong S., Choi .SK., Park S. et al. Measurement of antibodies to varicella-zoster virus using a virus-free fluorescent-antibodyto- membrane-antigen (FAMA) test Microbiol Biotechnol. 2015; 25 (2): 268 – 273.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
